Biomedical Applications of Nanomedicine in Chronic Kidney Disease
Bioengineering · 11.11.2026 · 13 (11) · 1336
DOI: 10.3390/bioengineering13111336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioengineering, online erschienen am 11.11.2026. Verfasst von Marcia Bastos Convento und 3 weiteren Autor:innen. Die Arbeit nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Nanomedicine has expanded biomedical applications in chronic kidney disease (CKD), including diagnostics, monitoring, targeted therapy, and extracorporeal management. However, heterogeneity in materials, experimental models, and translational development complicates assessment of clinical progress. This review characterized major CKD nanomedicine applications and their documented translational stages.
Methods
English-language original studies indexed in PubMed/MEDLINE between 1 July 2021 and 1 July 2026 were organized into 11 overlapping thematic categories and classified according to their highest documented translational stage.
Results
Of 288 records identified, 160 studies across 91 journals were included. The most frequent categories were nanodiagnostics and biosensors (53 studies), nanotherapy for renal fibrosis (51), kidney-targeted drug delivery (28), and redox nanomedicine, inflammation, and oxidative stress (27). Diagnostic platforms more frequently reached human-sample validation or early clinical evaluation, whereas therapeutic approaches remained predominantly preclinical. Extracorporeal nanotechnologies were largely experimental, with limited human-sample evaluation.
Conclusions
CKD nanomedicine exhibits substantial technological diversity but uneven translational development. Progress toward clinical implementation requires standardized physicochemical characterization, reproducibility, independent validation, long-term safety assessment, manufacturing scalability, and rigorous comparisons with established standards of care using clinically meaningful outcomes.
Zitieren
APA
Convento, M. B., Marchi, R. G. P., Silva, A. F. D., & Borges, F. T. (2026). Biomedical Applications of Nanomedicine in Chronic Kidney Disease. Bioengineering, 13(11), 1336. https://doi.org/10.3390/bioengineering13111336
Vancouver
Convento MB, Marchi RGP, Silva AFD, Borges FT. Biomedical Applications of Nanomedicine in Chronic Kidney Disease. Bioengineering. 2026;13(11):1336. doi:10.3390/bioengineering13111336
BibTeX
@article{Convento2026,
author = {Convento, Marcia Bastos and Marchi, Rodolfo Gabriel Pierre and Silva, Adelson Fernandes da and Borges, Fernanda Teixeira},
title = {Biomedical Applications of Nanomedicine in Chronic Kidney Disease},
journal = {Bioengineering},
year = {2026},
volume = {13},
number = {11},
pages = {1336},
doi = {10.3390/bioengineering13111336}
}
EUVIMED